Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member printed answering member label
tabling member	label

Search

1127177

	registered interest
	date	16/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reasons the statistics compiled by the NHS Business Services Authority are not shared in full with dental practice owners.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	255313
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The NHS Business Services Authority collects a wide range of data from dental practices as part of its role as payment agency for National Health Service dental remuneration. A sub set of this data is routinely published by NHS Digital and is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics</a></p><p>A further suite of management information is not routinely published but is directly shared with dental contract holders through the IT system used to manage remuneration known as Compass. Other data held by the NHS Business Services Authority is available by specific request subject to the usual rules on data protection.</p><p>Oversight of the NHS Business Services Authority overall is provided by the Department. The NHS Business Services Authority dental services carry out yearly research into user satisfaction with its services. This includes a survey of dental contract holders. The survey aims to identify areas for further improvement and the results are shared with the Department.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255314 question first answered 21/05/2019 16:15:59 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1127178

	registered interest
	date	16/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has collated feedback from NHS dental practitioners and NHS dental owners on the effectiveness of NHS Business Services Authority oversight procedures.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	255314
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The NHS Business Services Authority collects a wide range of data from dental practices as part of its role as payment agency for National Health Service dental remuneration. A sub set of this data is routinely published by NHS Digital and is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics</a></p><p>A further suite of management information is not routinely published but is directly shared with dental contract holders through the IT system used to manage remuneration known as Compass. Other data held by the NHS Business Services Authority is available by specific request subject to the usual rules on data protection.</p><p>Oversight of the NHS Business Services Authority overall is provided by the Department. The NHS Business Services Authority dental services carry out yearly research into user satisfaction with its services. This includes a survey of dental contract holders. The survey aims to identify areas for further improvement and the results are shared with the Department.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255313 question first answered 21/05/2019 16:15:59 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1126557

	registered interest
	date	14/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Sick Leave
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of officials in his Department took sick leave for reasons relating to stress in the last 12 months; what proportion that leave was of total sick leave taken in his Department; and what the cost was to his Department of officials taking sick leave over that period.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	254066
	answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The number of employees in the Department from 1 April 2018 to 31 March 2019 who were absent due to mental health reasons, including stress was 46, this represented 3% of the total workforce. The proportion of sickness absence related to mental health reasons, including stress, was 22% of the overall sickness absence for the Department for the same time period.</p><p> </p><p>The estimated cost to the Department from 1 April 2018 to 31 March 2019 for employees taking sickness absence, is estimated at £936,927.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/05/2019 10:28:23 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	151 label Biography information for Tom Brake

1127201

	registered interest
	date	16/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the ongoing negotiations between the NHS and Vertex pharmaceuticals on the price of cystic fibrosis drug Orkambi, if he will set out the priorities for the UK's delegation to the World Health Assembly, 21-26 May 2019; and if they will support the Italian Government's proposed resolution to improve the transparency of markets for drugs, vaccines and other health-related technologies to strengthen states positions when negotiating drug prices with industry.
	tabling member constituency	Sheffield, Brightside and Hillsborough
	tabling member printed	Gill Furniss
	uin	255358
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices. It is crucial that patients have access to the most effective and innovative medicines at a price that represents value to the National Health Service. The Government fully supports the approach the National Institute for Health and Care Excellence and NHS England are adopting in the ongoing negotiations with Vertex Pharmaceuticals on access to their portfolio of cystic fibrosis medicines.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 16:22:48 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4571 label Biography information for Gill Furniss

1127214

	registered interest
	date	16/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the draft resolution for consideration by the World Health Assembly in May 2019 on improving the transparency of markets for medicines, vaccines and other health-related technologies, if the Government will withdraw its support for suggested amendments to remove every mention of high prices.
	tabling member constituency	Liverpool, Walton
	tabling member printed	Dan Carden
	uin	255380
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255381 255382 question first answered 21/05/2019 16:12:54 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4651 label Biography information for Dan Carden

1127215

	registered interest
	date	16/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the draft resolution for consideration by the World Health Assembly in May 2019 on improving the transparency of markets for medicines, vaccines and other health-related technologies, if the Government will take steps to help ensure that the recommendation to member states calls for mandatory rather than voluntary measures.
	tabling member constituency	Liverpool, Walton
	tabling member printed	Dan Carden
	uin	255381
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255380 255382 question first answered 21/05/2019 16:12:54 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4651 label Biography information for Dan Carden

1127216

	registered interest
	date	16/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if the Government will support the draft resolution for consideration by the World Health Assembly in May 2019 on improving the transparency of markets for medicines, vaccines and other health-related technologies.
	tabling member constituency	Liverpool, Walton
	tabling member printed	Dan Carden
	uin	255382
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255380 255381 question first answered 21/05/2019 16:12:54 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4651 label Biography information for Dan Carden

1126924

	registered interest
	date	15/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of decreased funding for Public Health England on its ability to decrease health inequalities for people with epilepsy.
	tabling member constituency	Wantage
	tabling member printed	Mr Edward Vaizey
	uin	254782
	answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>No assessment has been made of the effect of funding for Public Health England (PHE) on its ability to reduce health inequalities for people with epilepsy.</p><p>PHE continues to provide data, intelligence and evidence-based advice to local authorities and the National Health Service on health inequalities and impacts for specific population groups.</p><p>In February 2018, PHE published data analysis for local authorities and the NHS highlighting the number and rate of deaths associated with epilepsy and other neurological conditions. The report identified inequalities in deaths associated with epilepsy and encourages local action. The report can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/publications/deaths-associated-with-neurological-conditions" target="_blank">https://www.gov.uk/government/publications/deaths-associated-with-neurological-conditions</a></p><p>PHE also provides access to intelligence resources on neurological conditions including epilepsy via the ‘Neurology data and analysis: a guide for health professionals’ page on Gov.uk, available to view at the following link:</p><p><a href="https://www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals" target="_blank">https://www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 24/05/2019 13:51:02 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1580 label Biography information for Lord Vaizey of Didcot

1126223

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Fires: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to introduce blood tests for effluents in public health checks after large-scale fires.
	tabling member constituency	Lincoln
	tabling member printed	Karen Lee
	uin	253723
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>Public Health England has no plans to introduce blood tests for effluents in public health checks after large-scale fires.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 16:26:03 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4664 label Biography information for Karen Lee

1126321

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Gender Dysphoria: Children
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they intend to publish the results of the research project started in 2011 by the NHS Gender Identity Development Service Early pubertal suppression in a carefully selected group of adolescents with gender identity disorder; and if not, whether they will arrange for the data gathered by that study to be made available to other researchers.
	tabling member printed	Lord Lucas
	uin	HL15681
	answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The research is an ethically approved study being carried out by the Tavistock and Portman NHS Foundation Trust since 2011, which is the largest provider of services for the alleviation of gender dysphoria in the United Kingdom.</p><p>The study will evaluate early pubertal suppression in a carefully selected group of adolescents with a clinical diagnosis of gender dysphoria. There are 44 young people taking part in the study.</p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish the data <ins class="ministerial">on the blocker and cross-sex hormones, for those who were appropriate for this, as</ins><del class="ministerial">once</del> all of the young people in the study have reached <ins class="ministerial">this</ins><del class="ministerial">the</del> stage<ins class="ministerial">.</ins> <del class="ministerial">when a clinical decision is made about moving from pubertal suppressants to cross-sex hormones, which the Trust expects to occur in the next 12 months.</del></p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:51:30 question first ministerially corrected 31/07/2019 15:30:59 answering member 4019 label Biography information for Baroness Blackwood of North Oxford previous answer version 119577 answering member printed Baroness Blackwood of North Oxford answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1879 label Biography information for Lord Lucas